title: Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment.
abstract: OBJECTIVE
  The possible autoimmune involvement of the pituitary gland in patients with celiac disease (CD) has been suggested but demonstrated in only a few patients on gluten-free diet. We aimed to assess the prevalence and clinical meaning of anti-pituitary antibodies (APA) in children and adolescents with the newly diagnosed CD.
  
  
  METHODS
  A total of 119 patients with CD (0.9-15.8 years old) attending the inpatient clinic of University Hospital were recruited for the cross-sectional study. Their height, weight, and body mass index (BMI) were recorded, and insulin-like growth factor-1 (IGF-1) and APA were assayed. APA was also determined in 98 sex- and age-matched controls.
  
  
  RESULTS
  APA were detected in 50 patients (42.0%), 15 of them with high titer (30%) and 35 with low titer (70%), and in 2 control subjects at low titer (2%) (P<0.001). IGF-1 was higher in patients with negative than with low titer (P=0.02) or high titer APA (P=0.03). Height was more reduced in high-titer APA patients than in the negative ones (P<0.01). Height was positively correlated with IGF-1 (P<0.01) and negatively with chronological age (P=0.001). IGF-1 was positively correlated with BMI (P<0.001). For height prediction the regression analysis showed the rank order 1 for chronological age and 2 for IGF-1.
  
  
  CONCLUSIONS
  In this paper we have shown a remarkable prevalence of positive APA in newly diagnosed CD patients. High APA titers are associated with height impairment, likely mediated by a reduction of IGF-1, thus suggesting that autoimmune pituitary process could induce a linear-growth impairment.
authors.affiliation: Unità Operativa Complessa di Pediatria, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. m.delvecchio@email.it
authors.forename: Maurizio
authors.initials: M
authors.lastname: Delvecchio
authors.forename: Annamaria
authors.initials: A
authors.lastname: De Bellis
authors.forename: Ruggiero
authors.initials: R
authors.lastname: Francavilla
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Rutigliano
authors.forename: Barbara
authors.initials: B
authors.lastname: Predieri
authors.forename: Flavia
authors.initials: F
authors.lastname: Indrio
authors.forename: Domenica
authors.initials: D
authors.lastname: De Venuto
authors.forename: Antonio Agostino
authors.initials: AA
authors.lastname: Sinisi
authors.forename: Antonio
authors.initials: A
authors.lastname: Bizzarro
authors.forename: Antonio
authors.initials: A
authors.lastname: Bellastella
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Iughetti
authors.forename: Luciano
authors.initials: L
authors.lastname: Cavallo
mesh_terms: D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D001827:Body Height; D015992:Body Mass Index; D001835:Body Weight; D002446:Celiac Disease / Q000276:immunology*; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D010902:Pituitary Gland / Q000276:immunology*; D012044:Regression Analysis
chemical_list: D000888:Antibodies, Anti-Idiotypic; D007334:Insulin-Like Growth Factor I